Live News Categoriesequity

Mesoblast Limited (MSB.AX) News

Track canonical SquawkNews coverage tagged to MSB.AX, Mesoblast Limited. This hub brings together deduplicated headlines about asx, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol MSB.AX Asset equity Sector Markets 90 days 1 Last 2.26 Updated Sep 24, 2026, 12:40 AM UTC Open live news feed

L BUZZ — Australia's Mesoblast rises on FDA approval for new potency assay for commercial Ryoncil * Shares of Mesoblast rise as much as 5.1% to A$2.29, their biggest intraday pct gain since August 28 * Shares hit their highest level since September 9 * The biotech company gets US FDA approval to implement new potency REGULATION | Sep 24, 2026, 12:40 AM UTC